Linklaters has advised Triton Partners and a consortium led by Triton Fund 6. Vinge has advised Bolero. Gernandt & Danielsson has advised the board of directors...
Consortium Launches Public Cash Offer to Acquire Cint Group AB
Oncopeptides Announces SEK 200 Million Rights Issue
Vinge has advised Oncopeptides AB (publ). Oncopeptides AB (publ) has announced a partially guaranteed rights issue expected to raise approximately SEK 200 million in gross proceeds...
Bolero Sells Shares in Ambea Through Accelerated Bookbuilding
Vinge has advised Bolero Holdings S.à r.l. Bolero Holdings S.à r.l. has completed the sale of shares in Ambea AB (publ) through an accelerated bookbuilding process...
Hansa Biopharma Completes SEK 671.5 Million Directed Share Issue
Vinge has advised Hansa Biopharma AB (publ). Hansa Biopharma AB (publ) has completed a directed share issue, raising approximately SEK 671.5 million before transaction costs. The...
Egetis Therapeutics Raises SEK 183 Million in Directed Share Issue
Vinge has advised Egetis Therapeutics. Egetis Therapeutics AB (publ), which is listed on Nasdaq Stockholm, has completed a directed share issue, raising approximately SEK 183 million...
Oncopeptides Executes Fully Guaranteed SEK 150 Million Rights Issue
Vinge has advised Oncopeptides AB (publ). Oncopeptides AB (publ) has completed a fully guaranteed rights issue expected to generate proceeds of approximately SEK 150 million before...
Bolero Sells Shares in Ambea AB via Accelerated Bookbuilding
Vinge has advised Bolero Holdings S.à r.l. Bolero Holdings S.à r.l. has completed the sale of shares in Ambea AB (publ) through an accelerated bookbuilding process...
Hansa Biopharma Completes SEK 232 Million Directed Share Issue and Debt Restructuring
Vinge has advised Hansa Biopharma AB (publ). Hansa Biopharma AB (publ) has executed a directed share issue, securing approximately SEK 232 million in gross proceeds, alongside...
RWK Bidco’s Acquisition of Biotage
Vinge advised Biotage on the deal. RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the...
Vimian Group AB’s Uplisting to Nasdaq Stockholm
Vinge advised Vimian Group AB on the deal. Vimian Group AB (publ) completed its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main...
Sedana Medical’s Acquisition of Innovatif Cekal
Vinge represented Sedana Medical AB on the deal. Sedana Medical AB (publ) finalized the acquisition of Innovatif Cekal. Innovatif Cekal, based in Klang near Kuala Lumpur,...
Pricer AB’s Bonds Offering
Vinge advised Pricer AB on the deal. Pricer AB (publ) completed its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework...